3-(4-dimethylaminobenzylidene)-1,3-dihydroindol-2-one,
SU 4312,
SU-4312,
SU4312,
SU 4312,
5812-07-7,
NSC86429,
dmbi,
SU4312,
NSC 86429,
CHEMBL328710,
SU-4312,
3-[[4-(dimethylamino)phenyl]methylene]-1,3-dihydro-2H-indol-2-one,
cis-SU 4312,
SR-01000076222,
3-(4-(Dimethylamino)benzylidene)-1,3-dihydro-2H-indol-2-one,
3-(4-dimethylamino-benzylidenyl)-2-indolinone,
BiomolKI_000054,
BiomolKI2_000060,
UPCMLD-DP118,
Lopac0_001121,
BMK1-F6,
BSPBio_000998,
AC1O52G9,
SCHEMBL1982207,
UPCMLD-DP118:001,
UPCMLD-DP118:002,
BDBM17747,
3-[[(4-Dimethyl-amino)phenyl]methylene]-1,3-dihydro-2H-indol-2-one, E/Z mixture,
HMS1362B19,
HMS1792B19,
HMS1990B19,
HMS3263B03,
HMS3403B19,
HMS3676D03,
90828-16-3,
BCP20743,
Tox21_501121,
BS0190,
NSC-86429,
STK946565,
ZINC12339625,
AKOS005640946,
CCG-100658,
LP01121,
SU4312(NSC86429),
IDI1_002094,
NCGC00025170-02,
NCGC00025170-03,
NCGC00025170-04,
NCGC00025170-05,
NCGC00025170-06,
NCGC00025170-07,
NCGC00025170-08,
NCGC00025170-09,
NCGC00025170-10,
NCGC00025170-11,
NCGC00025170-12,
NCGC00261806-01,
B6746,
EU-0101121,
EC-000.2453,
S 8567,
(Z)-3-(4-(dimethylamino)benzylidene)indolin-2-one,
SR-01000076222-1,
SR-01000076222-3,
BRD-K20287671-001-01-0,
(3Z)-3-[(4-dimethylaminophenyl)methylene]indolin-2-one,
DMBI; (Z)-3-(4-(dimethylamino)benzylidene)indolin-2-one,
(3Z)-3-[(4-dimethylaminophenyl)methylidene]-1H-indol-2-one,
(3Z)-3-[4-(dimethylamino)benzylidene]-1,3-dihydro-2H-indol-2-one,
(3Z)-3-{[4-(dimethylamino)phenyl]methylidene}-2,3-dihydro-1H-indol-2-one,
CID6450842,
3-(4-Dimethylaminobenzylidenyl)-2-indolinone,
C549541,
3-(4-dimethylaminobenzylidene)-1,3-dihydroindol-2-one,
2H-Indol-2-one, 3-[[4-(dimethylamino)phenyl]methylene]-1,3-dihydro,